1. Home
  2. BCAX vs ACCD Comparison

BCAX vs ACCD Comparison

Compare BCAX & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • ACCD
  • Stock Information
  • Founded
  • BCAX 2018
  • ACCD 2007
  • Country
  • BCAX United States
  • ACCD United States
  • Employees
  • BCAX N/A
  • ACCD N/A
  • Industry
  • BCAX
  • ACCD Business Services
  • Sector
  • BCAX
  • ACCD Consumer Discretionary
  • Exchange
  • BCAX NYSE
  • ACCD Nasdaq
  • Market Cap
  • BCAX 670.9M
  • ACCD 569.3M
  • IPO Year
  • BCAX 2024
  • ACCD 2020
  • Fundamental
  • Price
  • BCAX $13.03
  • ACCD $6.98
  • Analyst Decision
  • BCAX Strong Buy
  • ACCD Hold
  • Analyst Count
  • BCAX 6
  • ACCD 11
  • Target Price
  • BCAX $34.20
  • ACCD $6.22
  • AVG Volume (30 Days)
  • BCAX 603.5K
  • ACCD 713.5K
  • Earning Date
  • BCAX 03-27-2025
  • ACCD 04-24-2025
  • Dividend Yield
  • BCAX N/A
  • ACCD N/A
  • EPS Growth
  • BCAX N/A
  • ACCD N/A
  • EPS
  • BCAX N/A
  • ACCD N/A
  • Revenue
  • BCAX N/A
  • ACCD $446,718,000.00
  • Revenue This Year
  • BCAX N/A
  • ACCD $14.44
  • Revenue Next Year
  • BCAX N/A
  • ACCD $12.64
  • P/E Ratio
  • BCAX N/A
  • ACCD N/A
  • Revenue Growth
  • BCAX N/A
  • ACCD 14.99
  • 52 Week Low
  • BCAX $11.10
  • ACCD $3.08
  • 52 Week High
  • BCAX $28.09
  • ACCD $10.45
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • ACCD 66.70
  • Support Level
  • BCAX N/A
  • ACCD $6.95
  • Resistance Level
  • BCAX N/A
  • ACCD $6.99
  • Average True Range (ATR)
  • BCAX 0.00
  • ACCD 0.02
  • MACD
  • BCAX 0.00
  • ACCD -0.02
  • Stochastic Oscillator
  • BCAX 0.00
  • ACCD 25.00

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About ACCD Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Share on Social Networks: